Description
CD19 protein plays a central role in B cell activation and humoral immune responses. It is required for the responsiveness of mature B cell to antigen stimulation, germinal center development, and antibody affinity maturation. CD19 has emerged as promising therapeutic target for hematologic cancers and solid tumors.
Specifications
|
Synonyms |
CD19; B4; CVID3; Leu-12; MGC12802 |
|
Uniprot No. |
P15391-1 |
|
Source |
FITC-Compatible Human CD19 Protein is expressed from HEK293 Cells with His tag at the C-terminal. It contains Pro20-Lys291. |
|
Molecular Weight |
The protein has a predicted MW of 60.1 kDa. Due to glycosylation, the protein migrates to 68-72 kDa based on Tris-Bis PAGE result. |
|
Purity |
> 95% as determined by SDS-PAGE and HPLC |
|
Endotoxin |
< 1.0 EU per 1μg of the protein by the LAL method. |
|
Formulation |
Supplied as 0.22μm filtered solution in PBS (pH 7.4). |
Storage
The products are shipped with ice pack and can be stored at -80℃ for 1 year.
Recommend to aliquot the protein into smaller quantities for optimal storage. Please do not repeated freeze-thaw cycles.
Note
1.Please operate with lab coats and disposable gloves,for your safety.
2.This product is for research use only.
Product Data
Tris-Bis PAGE
Payment & Security
Your payment information is processed securely. We do not store credit card details nor have access to your credit card information.
Inquiry
You may also like
FAQ
The product is for research purposes only and is not intended for therapeutic or diagnostic use in humans or animals. Products and content are protected by patents, trademarks, and copyrights owned by Yeasen Biotechnology. Trademark symbols indicate the country of origin, not necessarily registration in all regions.
Certain applications may require additional third-party intellectual property rights.
Yeasen is dedicated to ethical science, believing our research should address critical questions while ensuring safety and ethical standards.